Fixed-duration ibrutinib–venetoclax versus chlorambucil–obinutuzumab in previously untreated chronic...
Fixed-duration ibrutinib–venetoclax versus chlorambucil–obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial
About this item
Full title
Author / Creator
Niemann, Carsten U, MD PhD , Munir, Talha, MBBS , Moreno, Carol, MD , Owen, Carolyn, MD , Follows, George A, Prof , Benjamini, Ohad, MD , Janssens, Ann, Prof , Levin, Mark-David, MD , Robak, Tadeusz, Prof , Simkovic, Martin, MD PhD , Voloshin, Sergey, Prof , Vorobyev, Vladimir, PhD , Yagci, Munci, Prof , Ysebaert, Loic, Prof , Qi, Keqin, PhD , Qi, Qianya, PhD , Sinet, Pierre, PharmD , Parisi, Lori, MPH , Srinivasan, Srimathi, PhD , Schuier, Natasha, MD , Baeten, Kurt, PhD , Howes, Angela, PhD , Caces, Donne Bennett, MD PhD and Kater, Arnon P, Prof
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
SummaryBackgroundIn the GLOW study, fixed-duration ibrutinib–venetoclax showed superior progression-free survival versus chlorambucil–obinutuzumab in patients with previously untreated chronic lymphocytic leukaemia who were older or had comorbidities, or both, at a median follow up of 27·7 months. In this Article, we report updated outcomes from GL...
Alternative Titles
Full title
Fixed-duration ibrutinib–venetoclax versus chlorambucil–obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial
Authors, Artists and Contributors
Author / Creator
Munir, Talha, MBBS
Moreno, Carol, MD
Owen, Carolyn, MD
Follows, George A, Prof
Benjamini, Ohad, MD
Janssens, Ann, Prof
Levin, Mark-David, MD
Robak, Tadeusz, Prof
Simkovic, Martin, MD PhD
Voloshin, Sergey, Prof
Vorobyev, Vladimir, PhD
Yagci, Munci, Prof
Ysebaert, Loic, Prof
Qi, Keqin, PhD
Qi, Qianya, PhD
Sinet, Pierre, PharmD
Parisi, Lori, MPH
Srinivasan, Srimathi, PhD
Schuier, Natasha, MD
Baeten, Kurt, PhD
Howes, Angela, PhD
Caces, Donne Bennett, MD PhD
Kater, Arnon P, Prof
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_inserm_04777948v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_inserm_04777948v1
Other Identifiers
ISSN
1470-2045,1474-5488
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(23)00452-7
